Core Insights - InStride has facilitated a partnership between Arizona State University (ASU) and Labcorp to launch a Master of Science in Cytology, addressing a critical shortage of cytotechnologists in the U.S. [1][2] - The program aims to provide accessible, high-quality training to meet the growing demand for cytotechnologists, with the first cohort starting in January 2025 [1][5]. Group 1: Partnership and Program Development - The collaboration was initiated at InStride's annual IMPACT summit, where leaders from ASU and Labcorp recognized the urgent need for trained cytotechnologists [3]. - The program was developed in just six months, showcasing the ability of universities to respond quickly to industry workforce needs [2][4]. Group 2: Educational Approach and Accessibility - The program combines ASU's online education expertise with hands-on clinical training, making cytology education available nationwide, unlike traditional programs concentrated in specific regions [5]. - Future expansions will allow enrollment beyond Labcorp employees and introduce undergraduate and certificate pathways in laboratory medicine [5]. Group 3: Industry Impact and Workforce Solutions - This partnership provides Labcorp with a scalable education solution to address workforce needs while offering clinical lab professionals a flexible pathway to advance their careers [6]. - Cytology is crucial for cancer screening and diagnosis, and the collaboration enables Labcorp employees to stay updated with advancements in diagnostic testing [7].
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage